Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes.

Detalles Bibliográficos
Publicado en:Journal of Clinical Pharmacology Vol. 51; no. 2; pp. 173 - 181
Autores principales: Loebstein, Ronen, Dushinat, Marina, Vesterman-Landes, Janet, Silverman, Barbara, Friedman, Nurit, Katzir, Itzhak, Kurnik, Daniel, Lomnicky, Yossef, Kokia, Ehud, Halkin, Hillel
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 02/01/2011
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104814141&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104814141
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00912700
        5WH
      jtl: Journal of Clinical Pharmacology
      issn: 00912700
      maglogo: Y
    pubinfo:
      dt: 02/01/2011
      vid: 51
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        104814141
        58013900
        10.1177/0091270010368281
        NLM20484611
        104814141
      ppf: 173
      ppct: 8
      formats:
      tig:
        atl: Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes.
      aug:
        au:
          Loebstein, Ronen
          Dushinat, Marina
          Vesterman-Landes, Janet
          Silverman, Barbara
          Friedman, Nurit
          Katzir, Itzhak
          Kurnik, Daniel
          Lomnicky, Yossef
          Kokia, Ehud
          Halkin, Hillel
        affil: Department of Pharmaceutics and Clinical Pharmacology, Department of Outcomes Research, Medical Division, Maccabi Healthcare Services, Tel Aviv, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, loebst_r@mac.org.il
      sug:
        subj:
          Rosiglitazone Adverse Effects
          Diabetes Mellitus, Type 2 Drug Therapy
          Cardiovascular Risk Factors
          Metformin Adverse Effects
          Drug Therapy, Combination Adverse Effects
          Diabetic Patients
          Retrospective Design
          Israel
          Registries, Disease
          Human
          Male
          Female
          Middle Age
          Aged
          Univariate Statistics
          Chi Square Test
          Analysis of Variance
          Cox Proportional Hazards Model
          Data Analysis Software
          Confidence Intervals
          Logistic Regression
          Meta Analysis
          Glycemic Control
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N